Cargando…
m(6)A RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer
N6-methyladenosine (m(6)A) is the most common form of mRNA modification, and is dynamically regulated by the m(6)A RNA methylation regulators. However, little is known about m(6)A in gastric cancer. The aim of this work is to investigate the effects of m(6)A RNA methylation regulators in gastric can...
Autores principales: | Su, Yunshu, Huang, Jinqi, Hu, Jichang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813557/ https://www.ncbi.nlm.nih.gov/pubmed/31681576 http://dx.doi.org/10.3389/fonc.2019.01038 |
Ejemplares similares
-
m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
por: Chai, Rui-Chao, et al.
Publicado: (2019) -
Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020) -
Genetic Alterations and Transcriptional Expression of m(6)A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma
por: Zhu, Gui-Qi, et al.
Publicado: (2020) -
Effect of m(6)A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
por: Wang, Jiawu, et al.
Publicado: (2020) -
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)